Cargando…

Correction to: Association between plasma interleukin-33 level and acute exacerbation of chronic obstructive pulmonary disease

Detalles Bibliográficos
Autores principales:	Joo, Hyonsoo, Park, Seoung Ju, Min, Kyung Hoon, Rhee, Chin Kook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556922/ https://www.ncbi.nlm.nih.gov/pubmed/34715830 http://dx.doi.org/10.1186/s12890-021-01703-3

Ejemplares similares

Association between plasma interleukin-33 level and acute exacerbation of chronic obstructive pulmonary disease
por: Joo, Hyonsoo, et al.
Publicado: (2021)

Association Between Air Pollution and Viral Infection in Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Choi, Juwhan, et al.
Publicado: (2023)

Development of a daily predictive model for the exacerbation of chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2023)

Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2020)

Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2022)

Correction: Evaluation of asthma–chronic obstructive pulmonary disease overlap using a mouse model of pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2023)

Factors associated with plasma IL-33 levels in patients with chronic obstructive pulmonary disease
por: Kim, Sei Won, et al.
Publicado: (2017)

Developmental endothelial locus-1 as a potential biomarker for the incidence of acute exacerbation in patients with chronic obstructive pulmonary disease
por: Joo, Dong-Hyun, et al.
Publicado: (2021)

Factors associated with chronic obstructive pulmonary disease exacerbation, based on big data analysis
por: Lee, Jongmin, et al.
Publicado: (2019)

Association between Serum Levels of Interleukin-25/Thymic Stromal Lymphopoietin and the Risk of Exacerbation of Chronic Obstructive Pulmonary Disease
por: Choi, Joon Young, et al.
Publicado: (2023)

Correction: Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
por: Sethi, Sanjay, et al.
Publicado: (2010)

A Multicenter Study to Identify the Respiratory Pathogens Associated with Exacerbation of Chronic Obstructive Pulmonary Disease in Korea
por: Lee, Hyun Woo, et al.
Publicado: (2022)

Correction: Laboratory-based intermountain validated exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease
Publicado: (2020)

Clinical significance of nuclear factor erythroid 2-related factor 2 in patients with chronic obstructive pulmonary disease
por: Ban, Woo Ho, et al.
Publicado: (2018)

Effect of Broncho-Vaxom (OM-85) on the frequency of chronic obstructive pulmonary disease (COPD) exacerbations
por: Choi, Joon Young, et al.
Publicado: (2023)

Frequent Outpatient Visits Prevent Exacerbation of Chronic Obstructive Pulmonary Disease
por: Park, Hye Jung, et al.
Publicado: (2020)

Risk of Rapid Lung Function Decline in Young Adults With Chronic Obstructive Pulmonary Disease: A Community-Based Prospective Cohort Study
por: Kim, Sang Hyuk, et al.
Publicado: (2022)

Definitions of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Exacerbation: A Modified Delphi Survey
por: Park, Yong Bum, et al.
Publicado: (2023)

Decreased serum club cell secretory protein in asthma and chronic obstructive pulmonary disease overlap: a pilot study
por: Oh, Jee Youn, et al.
Publicado: (2018)

High prevalence of chronic obstructive pulmonary disease in Korea
por: Rhee, Chin Kook
Publicado: (2016)

Risk factors for the discontinuation of roflumilast in patients with chronic obstructive pulmonary disease
por: Kim, Kyung Hoon, et al.
Publicado: (2017)

Metabolic Syndrome in Early Chronic Obstructive Pulmonary Disease: Gender Differences and Impact on Exacerbation and Medical Costs
por: Choi, Hye Sook, et al.
Publicado: (2019)

Clinical Role of the Chronic Obstructive Pulmonary Disease Assessment Test in Prediction of the Response to Treatment for Exacerbations
por: Yoon, Sunyoung, et al.
Publicado: (2019)

Phenotype of asthma-chronic obstructive pulmonary disease overlap syndrome
por: Rhee, Chin Kook
Publicado: (2015)

Correction to: Effect of timing of bronchodilator therapy initiation on exacerbations in patients with chronic obstructive pulmonary disease: a retrospective cohort study
por: Yamada, Hideyasu, et al.
Publicado: (2022)

Exacerbations of chronic obstructive pulmonary disease: When are antibiotics indicated? A systematic review
por: Puhan, Milo A, et al.
Publicado: (2008)

The global status of chronic obstructive pulmonary disease
por: Rhee, Chin Kook, et al.
Publicado: (2021)

Association of serum interleukin‐27 with the exacerbation of chronic obstructive pulmonary disease
por: Angata, Takashi, et al.
Publicado: (2014)

Mixed Phenotype of Emphysema and Airway Wall Thickening Is Associated with Frequent Exacerbation in Chronic Obstructive Pulmonary Disease Patients
por: Lim, Jeong Uk, et al.
Publicado: (2019)

Risk of acute exacerbations in chronic obstructive pulmonary disease associated with biomass smoke compared with tobacco smoke
por: Cho, Jaeyoung, et al.
Publicado: (2019)

Diaphragm Ultrasound is an Imaging Biomarker that Distinguishes Exacerbation Status from Stable Chronic Obstructive Pulmonary Disease
por: An, Tai Joon, et al.
Publicado: (2022)

Incidence of Adverse Effects and Discontinuation Rate between Patients Receiving 250 Micrograms and 500 Micrograms of Roflumilast: A Comparative Study
por: Joo, Hyonsoo, et al.
Publicado: (2018)

Heterogeneity of asthma–COPD overlap syndrome
por: Joo, Hyonsoo, et al.
Publicado: (2017)

A first case of high-flow nasal cannula oxygen therapy in patients with pulmonary tumor thrombotic microangiopathy
por: Joo, Hyonsoo, et al.
Publicado: (2017)

Three-month Treatment Response and Exacerbation in Chronic Obstructive Pulmonary Disease
por: Lee, Jung Su, et al.
Publicado: (2015)

Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease
por: Rhee, Chin Kook, et al.
Publicado: (2020)

The Significance of Serum Interleukin-8 in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Zhang, Jingxi, et al.
Publicado: (2018)

Interleukin-33 gene polymorphisms and chronic obstructive pulmonary disease in the Chinese Han population
por: Xu, Xia, et al.
Publicado: (2020)

Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD
por: Oh, Jee Youn, et al.
Publicado: (2018)

Correction: Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
por: Donahoe, Michael, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tvu01s7p5mac5hnmm0g0ut8io4